Company Search:
Advanced Search
Sponsored Links
PKU HealthCare Corp Ltd Company Snapshot
PKU HealthCare Corp Ltd operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares PKU HealthCare Corp Ltd with three other companies in this sector in CHINA : Asymchem Laboratories Tian Jin Co Ltd (2019 sales of 2.46 billion Chinese Renmimbi [US$361.22 million] of which 100% was Pharmaceutical industry), Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (2.47 billion Chinese Renmimbi [US$362.65 million] of which 100% was Pharmaceutical manufacture), and Hainan Haiyao Company Limited (2.45 billion Chinese Renmimbi [US$359.07 million] of which 70% was BPC).

Sales Analysis. PKU HealthCare Corp Ltd reported sales of 2.51 billion Chinese Renmimbi (US$368.43 million) for the year ending December of 2019. This represents an increase of 8.3% versus 2018, when the company's sales were 2.32 billion Chinese Renmimbi. This was the fourth straight year of sales growth at PKU HealthCare Corp Ltd. Sales of Medicine Production saw an increase that was more than double the company's growth rate: sales were up 25.6% in 2019, from 712.09 million Chinese Renmimbi to 894.11 million Chinese Renmimbi. Not all segments of PKU HealthCare Corp Ltd experienced an increase in sales in 2019: sales of Other Operation fell 30.6% to 13.35 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales). PKU HealthCare Corp Ltd also experienced decreases in sales in Others (down 13.5% to 2.90 million Chinese Renmimbi) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
PKU HealthCare Corp Ltd
  Stock Performance Chart for PKU HealthCare Corp Ltd
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 6.91
(Figures in Chinese Renmimbi)
1 Week 0.4%   13 Weeks -6.9%  
4 Weeks -1.4%   52 Weeks 3.0%  
PKU HealthCare Corp Ltd Key Data:
  Ticker: 000788 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2019 Sales 2,509,080,051
(Year Ending Jan 2020).
Employees: 841
  Currency: Chinese Renmimbi Market Cap: 4,118,273,107
  Fiscal Yr Ends: December Shares Outstanding: 595,987,425
  Share Type: A Gu Closely Held Shares: 266,420,805
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.